ArticleJournal of inflammation (London, England)2026
The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of MerTK.
Kieran A Bowden et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.